Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...
Showerheads and toothbrushes are teeming with an extremely diverse collection of viruses — most of which have never been seen ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...
Bacteriophages, the most abundant life form on Earth, infect bacterial cells and influence the structure of the microbial ...
Bacteria navigate tradeoffs between phage resistance and interbacterial competition. This study reveals that while LPS ...
The Human Virome Program will analyse samples from thousands of volunteers in an effort to understand how viruses affect ...
It is a great pleasure to announce that Professor Robert T. Schooley, from the University of California, San Diego (USA), ...
A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells.
Current decolonization methods for methicillin-resistant Staphylococcus aureus (MRSA) face several challenges, including resistance development or microbiome disruption. Hypharm GmbH has presented ...
A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells. This ...
Proceeds to support advancement of BX004 program through Phase 2b study topline results in cystic fibrosis (CF) patients, anticipated in Q1 2026 Financing will also support analysis of real-world ...
A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback